• ≡ İ
  • ≡ CHCAM
  • Ѷ
  • Shuzheng Health
  • Homepage
  • »
  • Collective liability for SFDA
  • Back
  • WHAT OUR CLIENTS SAY
  • "Shuzheng surpassed my expectations and took a genuine " --Tongrentang
  • "We sincerely apprec-iate the professional and courteous manner " --Jameison
  • Collective liability for SFDA
  • The State Food and Drug Administration (SFDA) will adopt a collective liability system under which officials involved in approving shady drugs will be exposed, a top official said yesterday. Wu Zhen, SFDA deputy director, said in an online interview posted yesterday on gov.cn that his heart "aches" over t...
  • 2007-02-28
  • The State Food and Drug Administration (SFDA) will adopt a collective liability system under which officials involved in approving shady drugs will be exposed, a top official said yesterday.

    Wu Zhen, SFDA deputy director, said in an online interview posted yesterday on gov.cn that his heart "aches" over the handful of corrupted officials who had tainted the SFDA system.

    As Wu made these comments, the SFDA was in the middle of corruption scandal following the downfalls of a several officials because of graft charges.

    And the 21st Century Business Herald reported yesterday that Zheng Shangjin, formerly an official with the Zhejiang Provincial Food and Drug Administration, had been detained for corruption.

    Public confidence in the country's top food and drug safety watchdog hit a new low in the wake of several food and drug crises that ended up costing dozens of lives last year.

    Wu said the SFDA would strengthen its oversight of the drug-approval process by adopting a collective liability system for all people who take part in the approval process.

    "The goal is to prevent any single person from abusing his power," Wu said.

    He said the SFDA would "leave no stone unturned" during investigations of any illicit activity and make sure that the identities of all parties involved in the approval process for a dangerous drug are announced in public.

    Wu denied that the SFDA had suspended granting approval to new drugs amid all the corruption scandals defended the national standard regime by saying that it would weed out substandard drugs.

    "Having a single standard is conducive to the supervision of drug safety," he said.
     
    Source: China Daily

  • Ѷ
  • Shuzheng Health
  • HomePrivacy PolicyTerm of UsesLinks© 2017 Shuzheng Health (Beijing) Commercial Consultation Co., Ltd.